Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 111,966 | 130,104 | 133,035 | 265,453 | 177,963 |
| Marketable Securities | 18,401 | 87,875 | 37,460 | 1,009 | 11,833 |
| Receivables | 4,175 | 1,033 | N/A | N/A | N/A |
| Inventories | 1,958 | 1,811 | N/A | N/A | N/A |
| Other current assets | 729 | 1,027 | 2,137 | 2,019 | 2,325 |
| TOTAL | $163,150 | $242,830 | $195,722 | $294,084 | $215,082 |
| Non-Current Assets | |||||
| PPE Net | 139,285 | 141,956 | 143,517 | 146,082 | 152,000 |
| Investments And Advances | 0 | 0 | 0 | 891 | 817 |
| Intangibles | 16,479 | 16,058 | 16,572 | 17,093 | 18,467 |
| Other Non-Current Assets | 45,656 | 43,481 | 44,868 | 46,302 | 46,053 |
| TOTAL | $201,420 | $201,495 | $204,957 | $210,368 | $217,337 |
| Total Assets | $364,570 | $444,325 | $400,679 | $504,452 | $432,419 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,331 | 20,517 | 14,965 | 10,331 | 21,090 |
| Accrued Expenses | 43,596 | 35,344 | 32,712 | 42,708 | 64,871 |
| TOTAL | $60,960 | $62,110 | $53,759 | $58,283 | $90,324 |
| Non-Current Liabilities | |||||
| Long Term Debt | 111,143 | 108,811 | 106,637 | 104,586 | 480,020 |
| Other Non-Current Liabilities | 936,652 | 970,802 | 931,287 | 927,542 | 272,780 |
| TOTAL | $1,047,772 | $1,079,593 | $1,037,903 | $1,032,106 | $752,740 |
| Total Liabilities | $1,108,732 | $1,141,703 | $1,091,662 | $1,090,389 | $843,064 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 696,831 | 696,533 | 691,568 | 673,952 | 667,705 |
| Common Shares | 70 | 69 | 68 | 67 | 67 |
| Retained earnings | -3,316,086 | -3,230,357 | -3,095,793 | -2,961,684 | -2,728,292 |
| Other shareholders' equity | 1,089 | 1,001 | 1,022 | 1,060 | 1,864 |
| TOTAL | $-744,162 | $-697,378 | $-690,983 | $-585,937 | $-410,645 |
| Total Liabilities And Equity | $364,570 | $444,325 | $400,679 | $504,452 | $432,419 |